Microbot Medical Inc.

NASDAQ: MBOT · Real-Time Price · USD
3.08
-0.05 (-1.60%)
At close: Aug 15, 2025, 3:59 PM
3.10
0.48%
After-hours: Aug 15, 2025, 05:08 PM EDT

Microbot Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
84K 84K 84K 142K 142K 142K 142K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
80K 94K 107K 100K 97K 109K 106K 104K 109K 106K 102K 97K 88K 79K 76K 48K 32K 18K
Gross Profit
4K -10K -23K -100K -97K -109K -106K -104K -109K -106K -102K -97K -88K -79K -76K -48K -32K -18K
Operating Income
-9.75M -12.26M -11.63M -10.26M -9.51M -9.32M -9.86M -10.86M -11.79M -13.02M -13.28M -14.15M -13.23M -12.14M -11.36M -10.05M -9.91M -9.32M
Interest Income
227K 273K 182K 144K 157K 148K 135K 210K 118K 131K 131K 56K 50K n/a n/a n/a n/a n/a
Pretax Income
-8.98M -11.67M -11.44M -11.21M -10.44M -10.26M -10.74M -10.58M -11.61M -12.83M -13.17M -14.03M -13.12M -12.11M -11.31M -10.09M -10.01M -9.35M
Net Income
-8.98M -11.67M -11.44M -11.21M -10.44M -10.26M -10.74M -10.58M -11.61M -12.83M -13.17M -14.03M -13.12M -12.11M -11.31M -10.09M -10.01M -9.35M
Selling & General & Admin
5.86M 5.34M 5M 4.49M 4.18M 4.04M 4.13M 4.6M 5.19M 5.6M 5.77M 6.25M 5.89M 5.61M 5.41M 5.35M 5.56M 5.69M
Research & Development
7.61M 6.92M 6.6M 5.75M 5.3M 5.25M 5.72M 6.48M 6.82M 7.65M 7.74M 8.11M 7.54M 6.74M 6.15M 4.9M 4.54M 3.82M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 112K 112K 112K 112K n/a n/a n/a
Operating Expenses
13.47M 12.26M 11.6M 10.23M 9.48M 9.29M 9.86M 10.86M 11.79M 13.02M 13.28M 14.15M 13.23M 12.14M 11.36M 10.05M 9.91M 9.32M
Interest Expense
n/a n/a n/a 66K 66K 66K 66K 7K 7K 7K 7K n/a 3K 3K 3K 13K 67K 67K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a 224K 224K 224K 224K 206K 206K 206K 206K 195K 195K 195K
Cost & Expenses
9.75M 12.26M 11.63M 10.26M 9.51M 9.32M 9.86M 10.86M 11.79M 13.02M 13.28M 14.15M 13.23M 12.14M 11.36M 10.05M 9.91M 9.32M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
36.49M 17.02M 17.02M 16.47M 14.85M 14.06M 12.13M 11.71M 9.2M 7.92M 7.72M 7.11M 7.11M 7.11M 7.11M 7.11M 7.11M 7.11M
Shares Outstanding (Diluted)
36.49M 17.02M 17.02M 16.47M 14.85M 14.06M 12.13M 11.71M 9.2M 8.01M 7.72M 7.11M 7.11M 7.11M 7.11M 7.11M 7.11M 7.11M
EPS (Basic)
-0.49 -0.56 -0.74 -0.8 -0.81 -0.89 -1.08 -1.21 -1.49 -1.73 -1.82 -1.97 -1.84 -1.7 -1.59 -1.42 -1.41 -1.32
EPS (Diluted)
-0.49 -0.56 -0.74 -0.8 -0.81 -0.89 -1.08 -1.21 -1.49 -1.73 -1.82 -1.97 -1.84 -1.7 -1.59 -1.42 -1.41 -1.32
EBITDA
-9.27M -11.76M -11.53M -10.44M -9.69M -9.49M -10.03M -10.75M -11.68M -12.92M -13.18M -14.05M -13.14M -12.06M -11.28M -9.98M -9.84M -9.25M
EBIT
-9.33M -11.84M -11.63M -10.54M -9.79M -9.6M -10.14M -10.86M -11.79M -13.02M -13.28M -14.15M -13.23M -12.14M -11.36M -10.05M -9.91M -9.32M
Depreciation & Amortization
64K 78K 91K 100K 97K 109K 106K 104K 109K 106K 102K 97K 88K 79K 76K 63K 66K 69K